The Bone Growth Stimulator Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2024-2033).
Learn More On The Bone Growth Stimulator Market:
https://www.thebusinessresearchcompany.com/report/bone-growth-stimulator-global-market-report
According to The Business Research Company’s Bone Growth Stimulator Global Market Report 2024, The bone growth stimulator market size has grown rapidly in recent years. It will grow from $1.53 billion in 2024 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 10.8%. The growth in the historic period can be attributed to aging population and orthopedic conditions, increasing awareness of non-invasive treatments, expansion of healthcare access, favorable reimbursement policies, increased demand for minimally invasive solutions , and increased orthopedic surgery prevalence.
The bone growth stimulator market size is expected to see strong growth in the next few years. It will grow to $2.45 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to enhanced public awareness, regenerative medicine adoption, healthcare infrastructure investments, expanding applications and indications, and supportive healthcare policies. Major trends in the forecast period include regenerative medicine, the use of 3d printing technology, incorporating wireless and iot technologies for remote patient monitoring, patient-centric care, and increasing utilization of telemedicine.
The rising number of bone fractures is expected to significantly drive the growth of the bone growth stimulators market. A person's bones typically weaken with age, dietary habitat, and other chronic disorders. The overuse or repetitive motions can tire muscles and put more pressure on the bones, leading to bone fracture. For instance, Amgen, a US-based biotechnology company, presented numbers in May 2022 stating that osteoporosis causes around 1.5 million fractures annually in the United States, resulting in $19 billion in associated expenses. In addition, it is predicted that from 2018 to 2040, there would be a 68% increase in the number of osteoporotic fractures every year, from 1.9 million to 3.2 million. Therefore, the rise in the number of bone fractures is expected to drive the growth of the bone growth stimulator market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=6885&type=smp
The bone growth stimulator market covered in this report is segmented –
1) By Type: Bone Growth Stimulation Devices, Bone Morphogenetic Proteins (BMP), Platelet-Rich Plasma (PRP) Therapy
2) By Type Of Use: Implantable Device, External Device
3) By Application: Fractures, Spinal Fusion, Osteogenesis, Arthrodesis Treatment, Spondylolithesis
4) By End User: Hospitals & ASCs, Speciality Clinics, Home Care
Technological advancement is a key trend gaining popularity in the bone growth stimulators market. Electrical Bone Growth Stimulation (EBGS) is a unique approach to accelerate healing and promote fusion success rates. Increased experience and widespread EBGS devices have led to significant advancements in stimulation paradigms and clinical outcomes. For instance, in May 2022, Orthofix Medical Inc., a US-based Spinal, orthopedic, bone development solution manufacturer declared that the U.S. Food and Drug Administration (FDA) granted pre-market approval for the AccelStim bone healing therapy Class III device. The AccelStim device is a nonsurgical therapy option for approved new fractures as well as fractures that are still healing (nonunions). To enhance fracture healing, the gadget delivers a Low-Intensity Pulsed Ultrasound (LIPUS) signal to assist the bone's natural healing process.
The bone growth stimulator market report table of contents includes:
Executive Summary
Bone Growth Stimulator Market Characteristics
Bone Growth Stimulator Market Trends And Strategies
Bone Growth Stimulator Market - Macro Economic Scenario
Global Bone Growth Stimulator Market Size and Growth
.
.
.
Global Bone Growth Stimulator Market Competitive Benchmarking
Global Bone Growth Stimulator Market Competitive Dashboard
Key Mergers And Acquisitions In The Bone Growth Stimulator Market
Bone Growth Stimulator Market Future Outlook and Potential Analysis
Appendix
Top 5 Major Key Players Are:
Arthrex Inc
DJO Global Inc
Stryker Corporation
Bioventus LLC
Zimmer Biomet Holdings Inc
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
According to the new market research report “ Bone Growth Stimulator Market by Product (Device, Bone Morphogenetic Protein, PRP), Application (Spinal Fusion, Delay Union & Non-union Bone Fracture, Oral-maxillofacial), End User (Hospitals, Home Care, Academia, CROs) - Global Forecasts to 2022” ", published by MarketsandMarkets™,The global bone growth stimulator market is estimated to reach USD 1.41 billion by 2022 from 1.03 billion at a CAGR of 5.4% during the forecast period.
Don’t miss out on business opportunities in Bone Growth Stimulator MarketProcedural benefits offered by bone stimulation devices in bone fracture treatment :Bone growth stimulation devices offer a cost-effective and safer alternative mode to treat orthopedic diseases as compared to traditional surgical therapies for nonunion bone fractures.
These devices have been reported to shorten the patient’s hospital stay as well as lessen the risks of complications and infections.
This is expected to aid the adoption of bone growth stimulation products among key end users.
This is also augmented by clinical evidence that validates the clinical efficacy of bone growth stimulation products in the effective and rapid bone regeneration as compared to traditional methodologies.Browse and in-depth TOC on “ Bone Growth Stimulator Market “66 - Tables67 - Figures 153 - PagesSpeak to Our Subject Expert: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=82341383Target AudienceBone growth stimulation products manufacturing companiesHealthcare institutions (hospitals and outpatient clinics)Distributors and suppliersResearch laboratories and academic institutionsGovernment and regulatory authoritiesNon-government and other associations/organizationsMarket research and consulting firmsContract research organizations (CROS) and contract manufacturing organizations (CMOS)Critical questions the report answers:What are the key growth strategies adopted by major global players to strengthen their market position across emerging and established regions?Greater clinical applications of PRP kits for early orthopedic recovery is an emerging market trend.
What revenue impact will it have in the coming years on the overall bone growth stimulator industry?Emerging countries have immense opportunities for the growth of bone growth stimulators, will this scenario continue?Request Research Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=82341383
